Human beta-mannosidosis urine was fractionated by gel permeation chromatography on Bio-Gel P-2 and by high performance liquid chromatography on Partisil 10 SAX. Besides the disaccharide Man beta 1-4GlcNAc as the major component, a sialic acid-containing compound was detected in an amount of 10% compared to that of Man beta 1-4GlcNAc. Structural characterization of the oligosaccharide and of its reduced analogue by sugar composition analysis, methylation analysis, gas-liquid chromatography-mass spectrometry, and 500-MHz 1H NMR spectroscopy gave conclusive evidence for a novel urinary constituent: NeuAc alpha 2-6Man beta 1-4GlcNAc. This linear trisaccharide can be considered as the result of an alpha 2-6-sialylation of the major accumulating compound, Man beta 1-4GlcNAc. The hitherto unknown linkage between sialic acid and mannose was shown to be susceptible to sialidase digestion.

Download full-text PDF

Source

Publication Analysis

Top Keywords

beta 1-4glcnac
16
man beta
12
sialyl-alpha 2-6-mannosyl-beta
4
2-6-mannosyl-beta 1-4-n-acetylglucosamine
4
1-4-n-acetylglucosamine novel
4
novel compound
4
compound occurring
4
occurring urine
4
urine patients
4
patients beta-mannosidosis
4

Similar Publications

A Revised Structure for the Glycolipid Terminus of K5 Heparosan Capsular Polysaccharide.

Biomolecules

November 2020

Department of Chemical and Biological Engineering, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180, USA.

The structure of heparosan capsular polysaccharide (CPS) has been determined using enzymatic digestion with nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry. Previous errors in the assignment of the glycolipid acceptor structure, from which heparosan is extended, have been corrected. The structure of heparosan CPS is GlcNAc -1,[4GlcA -1,4GlcNAc -1,]4GlcA -1,[4Kdo -2,7Kdo -2,]4Kdo -2,7Kdo -2,4Kdo -2,7Kdo -2,4Kdo -2,7Kdo -2,4Kdo -PG-I (C16:0 or C18:0) (where n is ~250 for a CPS of 100 kDa).

View Article and Find Full Text PDF

Expression of LacdiNAc groups on N-glycans among human tumors is complex.

Biomed Res Int

March 2015

Laboratory of Glycobiology, Department of Bioengineering, Nagaoka University of Technology, Nagaoka, Niigata 940-2188, Japan.

Aberrant glycosylation of proteins and lipids is one of the characteristic features of malignantly transformed cells. The GalNAc β 1 → 4GlcNAc (LacdiNAc or LDN) group at the nonreducing termini of both N- and O-glycans is not generally found in mammalian cells. We previously showed that the expression level of the LacdiNAc group in N-glycans decreases dramatically during the progression of human breast cancer.

View Article and Find Full Text PDF

Xenotransplantation of pig organs into primates leads to hyperacute rejection (HAR). Functional ablation of the pig α 1,3-galactosyltransferase (GalT) gene, which abrogates expression of the Gal α 1-3Gal β 1-4GlcNAc-R (Gal) antigen, which inhibits HAR. However, antigens other than Gal may induce immunological rejection by their cognate antibody responses.

View Article and Find Full Text PDF

B4GALT1 gene encodes type II membrane-bound glycoprotein, named β-1, 4-galactosyltransferase 1 (β1, 4-Gal-T1), which can transfer galactose to acceptor sugars. B4GALT1 gene plays important roles in physiological process and disease development. In this study, we investigate the possible role and mechanism of B4GALT1 gene in multidrug resistance of human leukemia cell line.

View Article and Find Full Text PDF

Objective: Calcification plays a major role in the failure of bioprosthetic and other tissue heart valve substitutes. The objective of this study was to evaluate the anticalcification effect of decellularization and detoxification in glutaraldehyde (GA)/genipin- and solvent-fixed bovine pericardium using a rabbit intramuscular model which is effective for assessing calcification in bioprosthetic tissue.

Methods: Bovine pericardial tissues were fixed with 0.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!